FDA Clearance Tracker · P200025
ClearVisc Ophthalmic Viscosurgical Device (OVD)
Last checked: Nov 19, 2026Latest source record: Mar 23, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Mar 23, 2021
Approved
Time to decision
337 days
Received Apr 20, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P200025
- Device name
- ClearVisc Ophthalmic Viscosurgical Device (OVD)
- Applicant
- Bausch Health
- Applicant location
- Bridgewater, NJ
- Received
- Apr 20, 2020
- Decided
- Mar 23, 2021
- Decision
- Approved
Device type
- Device type
- AID, SURGICAL, VISCOELASTIC (LZP)
- Device class
- Class III
- Regulation
- 21 CFR 886.4275
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the ClearVisc Ophthalmic Viscosurgical Device (OVD). ClearVisc is indicated for use as a surgical aid in ophthalmic anterior segment procedures including:1) Extraction of a cataract; and2) Implantation of an intraocular lens (IOL).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LZP. The earliest in FDA's data is P810031, decided Jan 14, 1983.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Bausch Health
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P220009 · Decided Feb 22, 2023 · 230 days after receipt
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
- BIAFINE Topical Cream510(k)
K190342 · Decided Oct 18, 2019 · 246 days after receipt
Device type: Dressing, Wound, Drug (FRO) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.